IRIDEA is a newly born University Spin off with a core business in drug discovery and development. The main focus of the company is the identification of small-molecule therapeutics with anti-angiogenic and anti-inflammatory properties.
President: Prof. Vincenzo Pavone
Chief Executive Officer: Dr Maria De Fenza
Chief Scientific Officer: Prof Daniele D’Alonzo
Company Details
- Employees
- 2
- Founded
- -
- Address
- Via Nuova, Cercola,campania 80040,italy
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.irideapharma.com
- HQ
- Cercola, Campania
- Competitors
- Qwell Pharmaceuticals, Inc, Imyun Pharmaceuticals, Thesan Pharmaceuticals, Wahi Pharmaceuticals Incorporation, AbCura Pharmaceuticals, Wallace Pharmaceuticals, Interactive Medical Technologies (IMT Labs) - a Division of Stason Pharmaceuticals, iRideArusha, Erimos Pharmaceuticals LLC, Tivorsan Pharmaceuticals.
Iridea Pharmaceuticals Questions
Iridea Pharmaceuticals's website is http://www.irideapharma.com
Iridea Pharmaceuticals's LinkedIn profile is https://it.linkedin.com/company/iridea-pharmaceuticals
Iridea Pharmaceuticals has
2 employees.
View email and phone details for 2
employees at Iridea Pharmaceuticals.
Iridea Pharmaceuticals's industry is
Biotechnology Research
Iridea Pharmaceuticals's top competitors are
Qwell Pharmaceuticals, Inc,
Imyun Pharmaceuticals,
Thesan Pharmaceuticals,
Wahi Pharmaceuticals Incorporation,
Abcura Pharmaceuticals,
Wallace Pharmaceuticals,
Interactive Medical Technologies (Imt Labs) - A Division Of Stason Pharmaceuticals,
Iridearusha,
Erimos Pharmaceuticals Llc,
Tivorsan Pharmaceuticals.
Iridea Pharmaceuticals's categories are Biotechnology Research
Iridea Pharmaceuticals's founding year is 2021
